CGS-CIMB Research Securities

CGS-CIMB expects Singtel to be on earnings recovery path for 1HFY22 with Bharti, Optus' growth - THE EDGE SINGAPORE

Broker's Calls

CGS-CIMB expects Singtel to be on earnings recovery path for 1HFY22 with Bharti, Optus' growth

Singtel primed for earnings recovery with help from associates.
Singapore's FSSTI sees rebound despite extension in domestic restrictions - THE EDGE SINGAPORE

STI watch

Singapore's FSSTI sees rebound despite extension in domestic restrictions

The FSSTI closed up 111.47 points or 3.61% m-o-m at 3,198.17 points in October.
Analysts mostly positive on ST Engineering following plans to acquire TransCore - THE EDGE SINGAPORE

Broker's Calls

Analysts mostly positive on ST Engineering following plans to acquire TransCore

The analysts have given ST Engineering a target price starting from $3.68.
Sembcorp Industries gets an 'add' call from CGS-CIMB as it 'gathers wind' - THE EDGE SINGAPORE

Broker's Calls

Sembcorp Industries gets an 'add' call from CGS-CIMB as it 'gathers wind'

This move is expected to give the counter a 36.5% upside from its $1.84 price
Credit Bureau Asia's venture into Vietnam gets it a thumbs up from CGS-CIMB - THE EDGE SINGAPORE

Broker's Calls

Credit Bureau Asia's venture into Vietnam gets it a thumbs up from CGS-CIMB

CGS-CIMB Research Securities is maintaining its “add” call and target price of $1.53 on Credit Bureau Asia/
Analysts maintain 'buy' on Ascott Residence Trust with TP of at least $1.21, as recovery 'underway' - THE EDGE SINGAPORE

Broker's Calls

Analysts maintain 'buy' on Ascott Residence Trust with TP of at least $1.21, as recovery 'underway'

As at 3.41pm, units in ART are trading flat at $1.03, or 0.92 times P/BV, according to CGS-CIMB’s estimates.
Asean faces tricky recovery amid vaccine endgame; Singapore's STI to 'move higher' with further re-opening - THE EDGE SINGAPORE

Asean

Asean faces tricky recovery amid vaccine endgame; Singapore's STI to 'move higher' with further re-opening

RHB's analysts have raised their end-2021 STI target to 3,410 points from their previous 3,280-point forecast
Analysts mixed on Raffles Medical even as it appears immunised to the Covid-19 bug - THE EDGE SINGAPORE

Broker's Calls

Analysts mixed on Raffles Medical even as it appears immunised to the Covid-19 bug

The group’s PATMI of $39.4 million beat expectations of analysts from RHB and CGS-CIMB.
Analysts mixed on FCT's performance after 3Q21 update - THE EDGE SINGAPORE

Broker's Calls

Analysts mixed on FCT's performance after 3Q21 update

Analysts from CGS-CIMB and RHB think that FCT's Central Plaza could be a potential candidate for divestment.
'Buy' Raffles Medical, as it benefits from Singapore's reopening: analysts - THE EDGE SINGAPORE

Broker's Calls

'Buy' Raffles Medical, as it benefits from Singapore's reopening: analysts

Jaiswal is maintaining his “buy” call on the company at a revised target price of $1.35.
×